CN104237505A - 一种检测阿司匹林和氯吡咯雷药物双重抵抗的试剂盒 - Google Patents
一种检测阿司匹林和氯吡咯雷药物双重抵抗的试剂盒 Download PDFInfo
- Publication number
- CN104237505A CN104237505A CN201410473417.XA CN201410473417A CN104237505A CN 104237505 A CN104237505 A CN 104237505A CN 201410473417 A CN201410473417 A CN 201410473417A CN 104237505 A CN104237505 A CN 104237505A
- Authority
- CN
- China
- Prior art keywords
- antibody
- liquid
- solution
- kit
- elisa plate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 title claims abstract description 24
- 229960001138 acetylsalicylic acid Drugs 0.000 title claims abstract description 24
- 239000003814 drug Substances 0.000 title claims abstract description 14
- 239000005552 B01AC04 - Clopidogrel Substances 0.000 title abstract description 10
- GKTWGGQPFAXNFI-HNNXBMFYSA-N clopidogrel Chemical compound C1([C@H](N2CC=3C=CSC=3CC2)C(=O)OC)=CC=CC=C1Cl GKTWGGQPFAXNFI-HNNXBMFYSA-N 0.000 title abstract description 10
- 229960003009 clopidogrel Drugs 0.000 title abstract description 10
- 229940079593 drug Drugs 0.000 title abstract description 6
- 239000000243 solution Substances 0.000 claims abstract description 26
- 239000008367 deionised water Substances 0.000 claims abstract description 15
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 102000004190 Enzymes Human genes 0.000 claims abstract description 12
- 108090000790 Enzymes Proteins 0.000 claims abstract description 12
- 239000012086 standard solution Substances 0.000 claims abstract description 12
- 238000002372 labelling Methods 0.000 claims abstract description 11
- 238000000034 method Methods 0.000 claims abstract description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000000758 substrate Substances 0.000 claims abstract description 10
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 claims abstract description 9
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims abstract description 9
- 229940098773 bovine serum albumin Drugs 0.000 claims abstract description 9
- 239000007853 buffer solution Substances 0.000 claims abstract description 9
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims abstract description 8
- 238000005406 washing Methods 0.000 claims abstract description 7
- 239000007788 liquid Substances 0.000 claims description 37
- 239000000872 buffer Substances 0.000 claims description 24
- 210000004027 cell Anatomy 0.000 claims description 20
- 230000009977 dual effect Effects 0.000 claims description 19
- QSMTUAJDOTXEDZ-UHFFFAOYSA-N N1C=CC=C1.[Cl] Chemical class N1C=CC=C1.[Cl] QSMTUAJDOTXEDZ-UHFFFAOYSA-N 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 14
- 239000003085 diluting agent Substances 0.000 claims description 12
- 239000002671 adjuvant Substances 0.000 claims description 10
- 230000001804 emulsifying effect Effects 0.000 claims description 10
- 238000002649 immunization Methods 0.000 claims description 10
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 8
- 108091006905 Human Serum Albumin Proteins 0.000 claims description 8
- 102000008100 Human Serum Albumin Human genes 0.000 claims description 8
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 claims description 8
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 8
- 229940005654 nitrite ion Drugs 0.000 claims description 8
- 239000008363 phosphate buffer Substances 0.000 claims description 8
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 8
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 8
- 235000020183 skimmed milk Nutrition 0.000 claims description 8
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 6
- 229910052782 aluminium Inorganic materials 0.000 claims description 6
- 239000004411 aluminium Substances 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 6
- 239000011248 coating agent Substances 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 6
- 238000010790 dilution Methods 0.000 claims description 6
- 239000012895 dilution Substances 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 5
- 206010035226 Plasma cell myeloma Diseases 0.000 claims description 5
- 239000012228 culture supernatant Substances 0.000 claims description 5
- 239000012634 fragment Substances 0.000 claims description 5
- 230000004927 fusion Effects 0.000 claims description 5
- 210000004408 hybridoma Anatomy 0.000 claims description 5
- 230000036039 immunity Effects 0.000 claims description 5
- 230000003053 immunization Effects 0.000 claims description 5
- 230000002163 immunogen Effects 0.000 claims description 5
- 238000002347 injection Methods 0.000 claims description 5
- 239000007924 injection Substances 0.000 claims description 5
- 201000000050 myeloid neoplasm Diseases 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 238000012216 screening Methods 0.000 claims description 5
- 238000005204 segregation Methods 0.000 claims description 5
- 210000004989 spleen cell Anatomy 0.000 claims description 5
- 210000004988 splenocyte Anatomy 0.000 claims description 5
- -1 hatch Substances 0.000 claims description 3
- 206010059866 Drug resistance Diseases 0.000 claims 1
- 210000002966 serum Anatomy 0.000 abstract description 10
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 abstract 2
- 238000003556 assay Methods 0.000 abstract 1
- 229960003624 creatine Drugs 0.000 abstract 1
- 239000006046 creatine Substances 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 239000008055 phosphate buffer solution Substances 0.000 abstract 1
- 239000012089 stop solution Substances 0.000 abstract 1
- 238000002835 absorbance Methods 0.000 description 15
- 238000001514 detection method Methods 0.000 description 11
- 238000012360 testing method Methods 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 230000002980 postoperative effect Effects 0.000 description 8
- 238000002965 ELISA Methods 0.000 description 6
- 239000003146 anticoagulant agent Substances 0.000 description 5
- 208000029078 coronary artery disease Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229940127219 anticoagulant drug Drugs 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000005057 refrigeration Methods 0.000 description 3
- 206010000891 acute myocardial infarction Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 229940127218 antiplatelet drug Drugs 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- 102000004420 Creatine Kinase Human genes 0.000 description 1
- 108010042126 Creatine kinase Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 208000025870 aspirin resistance Diseases 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 210000002318 cardia Anatomy 0.000 description 1
- 238000013194 cardioversion Methods 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000011977 dual antiplatelet therapy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000011285 therapeutic regimen Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410473417.XA CN104237505B (zh) | 2014-09-17 | 2014-09-17 | 一种检测阿司匹林和氯吡咯雷药物双重抵抗的试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410473417.XA CN104237505B (zh) | 2014-09-17 | 2014-09-17 | 一种检测阿司匹林和氯吡咯雷药物双重抵抗的试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104237505A true CN104237505A (zh) | 2014-12-24 |
CN104237505B CN104237505B (zh) | 2016-05-04 |
Family
ID=52225995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410473417.XA Active CN104237505B (zh) | 2014-09-17 | 2014-09-17 | 一种检测阿司匹林和氯吡咯雷药物双重抵抗的试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104237505B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018001259A1 (zh) * | 2016-06-29 | 2018-01-04 | 南京市第一医院 | ABCC3-013 mRNA在制备检测氯吡格雷抵抗的试剂盒中的应用及其试剂盒 |
CN109374897A (zh) * | 2018-11-22 | 2019-02-22 | 大连大学 | 一种用于肝癌检测的试剂盒 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1368888A (zh) * | 2000-02-08 | 2002-09-11 | 金晓骏 | 用于心脏病的抗人线粒体腺苷酸激酶同工酶抗体,诊断制剂和诊断试剂盒 |
CN101762704A (zh) * | 2008-12-26 | 2010-06-30 | 上海裕隆生物科技有限公司 | 一种单克隆抗体制备方法及其应用 |
CN102154216A (zh) * | 2010-12-31 | 2011-08-17 | 北京利德曼生化股份有限公司研发中心 | 抗ckm单克隆抗体与产生其的杂交瘤细胞株以及其的应用 |
CN102746382A (zh) * | 2012-07-27 | 2012-10-24 | 重庆业为基生物科技有限公司 | 心脏型脂肪酸结合蛋白b细胞表位肽及其抗体和应用 |
CN102809651A (zh) * | 2012-07-26 | 2012-12-05 | 博奥赛斯(天津)生物科技有限公司 | 肌酸磷酸激酶同工酶化学发光免疫定量检测试剂盒及其制备方法 |
-
2014
- 2014-09-17 CN CN201410473417.XA patent/CN104237505B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1368888A (zh) * | 2000-02-08 | 2002-09-11 | 金晓骏 | 用于心脏病的抗人线粒体腺苷酸激酶同工酶抗体,诊断制剂和诊断试剂盒 |
CN101762704A (zh) * | 2008-12-26 | 2010-06-30 | 上海裕隆生物科技有限公司 | 一种单克隆抗体制备方法及其应用 |
CN102154216A (zh) * | 2010-12-31 | 2011-08-17 | 北京利德曼生化股份有限公司研发中心 | 抗ckm单克隆抗体与产生其的杂交瘤细胞株以及其的应用 |
CN102809651A (zh) * | 2012-07-26 | 2012-12-05 | 博奥赛斯(天津)生物科技有限公司 | 肌酸磷酸激酶同工酶化学发光免疫定量检测试剂盒及其制备方法 |
CN102746382A (zh) * | 2012-07-27 | 2012-10-24 | 重庆业为基生物科技有限公司 | 心脏型脂肪酸结合蛋白b细胞表位肽及其抗体和应用 |
Non-Patent Citations (1)
Title |
---|
皓尘生物网: "人肌酸激酶同工酶MB(CK-MB)ELISA试剂盒", 《HTTP://WWW.HAOCHENGBIO.COM/HAOCHEN20132013-DOWN-1224371/》, 19 December 2013 (2013-12-19) * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018001259A1 (zh) * | 2016-06-29 | 2018-01-04 | 南京市第一医院 | ABCC3-013 mRNA在制备检测氯吡格雷抵抗的试剂盒中的应用及其试剂盒 |
CN109374897A (zh) * | 2018-11-22 | 2019-02-22 | 大连大学 | 一种用于肝癌检测的试剂盒 |
CN109374897B (zh) * | 2018-11-22 | 2021-11-02 | 大连大学 | 一种用于肝癌检测的试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
CN104237505B (zh) | 2016-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103901201B (zh) | 头孢氨苄残留荧光免疫层析检测试纸条及其制备 | |
CN104849464B (zh) | 一种检测阿司匹林疗效的试剂盒及其检测方法 | |
CN1811436B (zh) | 一种检测恩诺沙星的方法及其专用酶联免疫试剂盒 | |
EP3216460B1 (en) | Antigen polypeptide for detecting plasma immunological marker-vegfr1 autoantibody and use thereof | |
CN101403752A (zh) | 一种加替沙星的化学发光酶联免疫检测试剂盒 | |
Katayama et al. | Hepatitis B virus infection in hemodialysis patients in Japan: Prevalence, incidence and occult hepatitis B virus infection | |
CN105277708A (zh) | 检测辣椒中黄曲霉毒素b1的酶联免疫试剂盒 | |
CN101013131B (zh) | 呋喃妥因代谢物酶联免疫分析试剂盒及其应用 | |
CN103288872A (zh) | 甲基对硫磷半抗原及其制备方法和应用 | |
CN104237505A (zh) | 一种检测阿司匹林和氯吡咯雷药物双重抵抗的试剂盒 | |
CN101538266A (zh) | 罗格列酮半抗原、人工抗原和抗体及其制备方法和应用 | |
CN101981452B (zh) | 肺炎球菌检测方法 | |
EP3092497A1 (en) | Lateral flow immunoassays for the detection of antibodies against biological drugs | |
Builder et al. | Equilibrium ligand binding assays using labeled substrates: nature of the errors introduced by radiochemical impurities | |
CN102766212A (zh) | 用于检测氟喹诺酮类药物残留的单克隆抗体及酶联免疫方法与试剂盒 | |
Lam et al. | KRAS mutation‐independent downregulation of MAPK/PI3K signaling in colorectal cancer | |
CN107677807A (zh) | 一种吉他霉素磁免疫化学发光检测试剂盒 | |
CN105399639A (zh) | 一种酪胺人工抗原和抗体及其制备方法与应用 | |
CN104109112A (zh) | 赛庚啶半抗原、人工抗原和抗体及其制备方法和应用 | |
CN106771273B (zh) | 一种检测福莫特罗胶体金免疫层析试纸条及制备方法与应用 | |
CN106153954A (zh) | 一种苯妥英钠的快速检测方法 | |
CN105353095A (zh) | 一种西地那非及其结构类似物的免疫检测方法 | |
CN105628923B (zh) | 一种半定量免疫胶体金试纸条及其应用 | |
CN109459565B (zh) | 人血清C4BP-a蛋白作为预测氯吡格雷抵抗的生物标志物及其临床应用 | |
CN104130978B (zh) | 一种杂交瘤细胞株11a2及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210422 Address after: Room 402, building 3, 1500 Wenyi West Road, Cangqian street, Yuhang District, Hangzhou City, Zhejiang Province Patentee after: HANGZHOU S-EVANS BIOSCIENCES, Ltd. Address before: 310058 Yuhang, Zhejiang, Tong Road, No. 866, No. Patentee before: HANGZHOU THOMAS BIOTECHNOLOGY Ltd. |
|
TR01 | Transfer of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A reagent kit for detecting dual resistance to aspirin and clopidogrel drugs Granted publication date: 20160504 Pledgee: Zhejiang Hangzhou Yuhang Rural Commercial Bank Co.,Ltd. Science and Technology City Branch Pledgor: HANGZHOU S-EVANS BIOSCIENCES, Ltd. Registration number: Y2024980003656 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |